Targeted Genomic Integration for Stable Recombinant Protein Expression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Traditional cell line engineering methods for recombinant therapeutic protein expression result in unstable and diverse clonal populations due to random integration of transgenes, leading to inconsistent expression levels and protein heterogeneity.
Innovation Solution
Site-specific targeted integration of exogenous sequences into predefined genomic loci, such as the regions bp 1,090,000 to bp 1,127,000 of NCBI Reference Sequence NW_003613934.1, using targeting endonucleases and donor polynucleotides to ensure stable and predictable expression without affecting cellular function.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If random integration of transgenes is used, then cell lines can be developed for recombinant therapeutic protein expression, but the cell lines become unstable and show marked diversity in expression level and protein heterogeneity
Solution Approach 1:
The patent segments the genome into specific targetable loci with defined boundaries (e.g., attP sites, loxP sites, FRT sites). By dividing the genome into discrete integration regions with specific recognition sequences, the patent enables controlled integration at predetermined locations rather than random integration, thereby achieving both high expression and clonal stability.
Solution Approach 2:
The patent uses site-specific recombinases (Cre, Flp, Bxb1, etc.) as intermediary enzymes that mediate the integration of exogenous sequences into specific genomic loci. These recombinases recognize specific DNA sequences and catalyze precise recombination events, serving as intermediaries between the transgene and the genome to achieve stable, targeted integration without random insertion.
2Reliability
If site-specific targeted integration is used, then stable and predictable expression is achieved, but suitable genomic locations must be identified and verified
Solution Approach 1:
The patent performs preliminary identification and characterization of suitable genomic integration sites before actual transgene integration. Specific loci are pre-selected based on criteria such as being in genomic regions that support high expression, having available flanking sequences for recombinase recognition, and not disrupting essential cellular genes. This preliminary preparation simplifies subsequent integration processes.
Solution Approach 2:
The patent develops universal genomic loci that can accept multiple different transgenes and expression cassettes through the same recombinase recognition sites. These universal integration sites serve multiple functions: they can integrate various therapeutic proteins, accommodate different selectable markers, and work with multiple recombinase systems, thereby reducing the need to identify separate sites for each integration event.
3Productivity
If multiple exogenous sequences are integrated into the genome, then protein expression can be enhanced, but integration into non-functional regions may cause gene silencing or position effects
Solution Approach 1:
The patent integrates exogenous sequences into specific local genomic regions that have been characterized to support high, stable expression without silencing. These localized integration sites are selected for their favorable chromatin environment, appropriate histone modifications, and distance from heterochromatic regions. By controlling the local quality of the integration site, the patent enhances expression while avoiding position effects.
Solution Approach 2:
The patent uses site-specific recombinases to convert the potential harm of random integration into the benefit of precise, controlled integration. The recombinase system, which could otherwise cause unwanted genomic rearrangements, is instead harnessed to achieve accurate insertion at predetermined safe harbor loci, transforming a source of instability into a tool for reliable, reproducible integration.
Data Source
Figure 1A
Figure 1B
Figure 2
AI summary
Methods for integrating exogenous sequences in genomic loci, wherein the integration is stable and the exogenous sequence can function predictably and reliably.